The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4963120 6026187 I 4963120-9 20060317 20060331 EXP 2006-00651 MILLENIUM PHARMACEUTICALS INC. N 20060327 MD UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4963120 1007131907 PS VELCADE 1 INTRAVENOUS BOLUS IV BOLUS U U 21602
4963120 1007173159 SS DOXORUBICIN(DOXORUBICIN) 2 INTRAVENOUS 30,00 MG/M2, INTRAVENOUS

Indications of drugs used

Event ID DRUG SEQ INDI PT
4963120 1007131907 NON-HODGKIN'S LYMPHOMA
4963120 1007173159 NON-HODGKIN'S LYMPHOMA

Outcome of event

Event ID OUTC COD
4963120 DE

Reactions reported

Event ID PT
4963120 DISEASE PROGRESSION

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4963120 HP
4963120 LIT
4963120 SDY

Therapies reported

no results found